Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
440 GBX | -3.00% | -3.85% | -9.65% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Apr. 19 | Peel Hunt starts NatWest and Barclays at 'buy' | AN |
Sales 2024 * | 1.83B 2.33B | Sales 2025 * | 1.97B 2.51B | Capitalization | 1.38B 1.76B |
---|---|---|---|---|---|
Net income 2024 * | 61M 77.6M | Net income 2025 * | 88M 112M | EV / Sales 2024 * | 0.75 x |
Net cash position 2024 * | 170K 216K | Net cash position 2025 * | 3.47M 4.42M | EV / Sales 2025 * | 0.7 x |
P/E ratio 2024 * |
22.3
x | P/E ratio 2025 * |
15
x | Employees | 7,859 |
Yield 2024 * |
5.45% | Yield 2025 * |
6.47% | Free-Float | 94.58% |
Latest transcript on PageGroup plc
1 day | -3.00% | ||
1 week | -3.85% | ||
Current month | -3.85% | ||
1 month | -0.45% | ||
3 months | -4.14% | ||
6 months | -5.09% | ||
Current year | -9.65% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Kirk
CEO | Chief Executive Officer | - | 22-12-31 |
Director of Finance/CFO | 52 | 06-06-30 | |
Kaye Maguire
LAW | General Counsel | - | 18-09-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marie Metayer
BRD | Director/Board Member | 64 | 17-08-31 |
Director of Finance/CFO | 52 | 06-06-30 | |
Karen Geary
BRD | Director/Board Member | - | 22-03-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 775 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - | |
0.00% | 47 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 440 | -3.00% | 283,501 |
24-06-06 | 453.6 | +0.84% | 287,337 |
24-06-05 | 449.8 | -1.40% | 282,863 |
24-06-04 | 456.2 | -1.72% | 226,958 |
24-06-03 | 464.2 | +1.44% | 302,155 |
Delayed Quote London S.E., June 07, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-9.65% | 1.76B | |
+6.60% | 3.3B | |
-2.93% | 2.14B | |
+13.58% | 679M |
- Stock Market
- Equities
- PAGE Stock